Epidemiologist
US Food and Drug Administration
Silver Spring, Maryland, United States
US Food and Drug Administration (Employment, This abstract reflects the views of the author and should not be construed to represent FDA’s views or policies)
Monday, August 23, 2021
5:30 PM – 6:30 PM US Eastern Time
L-1C - Outpatient-identified COVID-19 and Subsequent Hospitalized Thrombotic Events
Monday, August 23, 2021
5:30 PM – 6:30 PM US Eastern Time
WS-18 - Strategies for the Use of Real-world Data to Conduct covid-19-related Pharmacoepidemiology
Wednesday, August 25, 2021
10:00 AM – 11:30 AM US Eastern Time